Holders over time
- CVS
- PM
| Quarter | CVS | PM |
|---|---|---|
| Q3 2020 | 29 holders, $8.9bn | 25 holders, $19.7bn |
| Q4 2020 | 22 holders, $9.8bn | 25 holders, $21.5bn |
| Q1 2021 | 28 holders, $10.3bn | 27 holders, $22.1bn |
| Q2 2021 | 24 holders, $11.8bn | 20 holders, $23.2bn |
| Q3 2021 | 28 holders, $11.9bn | 25 holders, $22.8bn |
| Q4 2021 | 28 holders, $14.7bn | 26 holders, $22.3bn |
| Q1 2022 | 25 holders, $14.4bn | 29 holders, $23.2bn |
| Q2 2022 | 30 holders, $13.5bn | 28 holders, $25.8bn |
| Q3 2022 | 28 holders, $13.9bn | 33 holders, $22.2bn |
| Q4 2022 | 30 holders, $12.6bn | 26 holders, $27.0bn |
| Q1 2023 | 36 holders, $9.6bn | 36 holders, $27.6bn |
| Q2 2023 | 33 holders, $9.8bn | 29 holders, $28.9bn |
| Q3 2023 | 33 holders, $11.7bn | 32 holders, $28.5bn |
| Q4 2023 | 32 holders, $14.2bn | 34 holders, $28.8bn |
| Q1 2024 | 21 holders, $14.3bn | 36 holders, $28.4bn |
| Q2 2024 | 24 holders, $14.2bn | 31 holders, $31.4bn |
| Q3 2024 | 31 holders, $14.2bn | 39 holders, $38.2bn |
| Q4 2024 | 32 holders, $11.0bn | 40 holders, $36.6bn |
| Q1 2025 | 29 holders, $19.1bn | 44 holders, $49.1bn |
| Q2 2025 | 31 holders, $19.6bn | 44 holders, $54.3bn |
| Q3 2025 | 28 holders, $21.9bn | 36 holders, $49.3bn |
| Q4 2025 | 29 holders, $22.8bn | 26 holders, $50.5bn |
| Q1 2026 | 32 holders, $21.1bn | 25 holders, $57.3bn |
| Q2 2026 | 31 holders, $30.8bn | 27 holders, $63.8bn |
CVS Health Corp
- Holders
- 32
- Reported value
- $21.1bn
- Buyers
- 24
- Sellers
- 20
Breadth +4 among 91 comparable managers.
Philip Morris Intl Inc
- Holders
- 25
- Reported value
- $57.3bn
- Buyers
- 22
- Sellers
- 17
Breadth +5 among 91 comparable managers.
Who holds both, Q1 2026
Both (18)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Capital Research Global Investors, Capital World Investors, Dodge & Cox, Fidelity (FMR LLC), Harris Associates LP, Invesco Ltd, Janus Henderson Group Ltd, Maverick Capital Ltd, Neuberger Berman Group LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Wellington Management Group LLP, Winton Group Ltd, Woodline Partners LP
Only CVS (14)
Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Citadel Advisors LLC, D. E. Shaw & Co., Davidson Kempner Capital Management LP, ExodusPoint Capital Management LP, Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Holocene Advisors LP, Man Group PLC, Marshall Wace LLP, Tudor Investment Corp
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.